The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.

Since July 2024, faricimab has also been approved in Europe for the treatment of visual impairment due to macular edema ...

Fresenius, through its operating company Fresenius Kabi, is broadening its growing biopharma portfolio through a new licensing agreement with South Korea’s SamChunDang Pharm. Under the agreement, ...

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced central ...

Jedd Comiskey, Senior Vice President, Head of Europe, highlights the recent NICE recommendation of LYTENAVA™ (bevacizumab gamma) for the treatment of wet AMD Access the segment here ISELIN, N.J., Jan.

Shares of Outlook Therapeutics jumped after the company said it continues to progress the development of its treatment for wet age-related macular degeneration, which causes blurred or reduced ...

For every 10 people who have macular degeneration, one or two will get wet AMD. But spotting the wet AMD symptoms early will help you get treatment and prevent vision loss. Blurry vision or other ...

SolidddVision smart glasses aim to restore vision for people living with macular degeneration, a condition that affects ...

Wet macular degeneration is a specific subtype of age ... These tests may also be used to assess your response to treatment. Fluorescein angiogram: A fluorescent dye is injected into your arm ...

Phase 1b clinical data underpins sozinibercept’s potential as a novel, first-in-class VEGF-C/D ‘trap’ to improve visual and anatomic outcomes in ...

A new eye drop therapy offers a non-invasive alternative for treating dry age-related macular degeneration. Massively ...